{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:41:37Z","timestamp":1774330897810,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-018-1459-6","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T09:39:53Z","timestamp":1533721193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2961-1238","authenticated-orcid":false,"given":"Hiroshi","family":"Urakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Yonemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munenori","family":"Watanuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kunisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiko","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Emori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hiraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tsukushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Akisue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Morii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihide","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"1459_CR1","unstructured":"Fletcher CDM. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013."},{"key":"1459_CR2","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3892\/ol.2016.4264","volume":"11","author":"N Futamura","year":"2016","unstructured":"Futamura N, Urakawa H, Tsukushi S, Arai E, Kozawa E, Ishiguro N, Nishida Y. Giant cell tumor of bone arising in long bones possibly originates from the metaphyseal region. Oncol Lett. 2016;11:2629\u201334.","journal-title":"Oncol Lett"},{"key":"1459_CR3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","volume":"134","author":"M Balke","year":"2008","unstructured":"Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008;134:969\u201378.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1459_CR4","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1302\/0301-620X.93B12.27663","volume":"93","author":"CL Gaston","year":"2011","unstructured":"Gaston CL, Bhumbra R, Watanuki M, Abudu AT, Carter SR, Jeys LM, Tillman RM, Grimer RJ. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Joint Surg Br. 2011;93:1665\u20139.","journal-title":"J Bone Joint Surg Br"},{"key":"1459_CR5","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.M.00516","volume":"96","author":"L van der Heijden","year":"2014","unstructured":"van der Heijden L, van der Geest IC, Schreuder HW, van de Sande MA, Dijkstra PD. Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers. J Bone Joint Surg Am. 2014;96:e35.","journal-title":"J Bone Joint Surg Am"},{"key":"1459_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/1471-2474-15-330","volume":"15","author":"ZH Gao","year":"2014","unstructured":"Gao ZH, Yin JQ, Xie XB, Zou CY, Huang G, Wang J, Shen JN. Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement. BMC Musculoskelet Disord. 2014;15:330.","journal-title":"BMC Musculoskelet Disord"},{"key":"1459_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1440-1827.1998.tb03973.x","volume":"48","author":"F Masui","year":"1998","unstructured":"Masui F, Ushigome S, Fujii K. Giant cell tumor of bone: a clinicopathologic study of prognostic factors. Pathol Int. 1998;48:723\u20139.","journal-title":"Pathol Int"},{"key":"1459_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1302\/0301-620X.80B1.7875","volume":"80","author":"KA Siebenrock","year":"1998","unstructured":"Siebenrock KA, Unni KK, Rock MG. Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg Br. 1998;80:43\u20137.","journal-title":"J Bone Joint Surg Br"},{"key":"1459_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2106\/JBJS.D.02771","volume":"90","author":"K Arbeitsgemeinschaft","year":"2008","unstructured":"Arbeitsgemeinschaft K, Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, et al. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008;90:1060\u20137.","journal-title":"J Bone Joint Surg Am"},{"key":"1459_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3928\/01477447-20090527-08","volume":"32","author":"K Muramatsu","year":"2009","unstructured":"Muramatsu K, Ihara K, Taguchi T. Treatment of giant cell tumor of long bones: clinical outcome and reconstructive strategy for lower and upper limbs. Orthopedics. 2009;32:491.","journal-title":"Orthopedics"},{"key":"1459_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jjco\/28.5.323","volume":"28","author":"Y Oda","year":"1998","unstructured":"Oda Y, Miura H, Tsuneyoshi M, Iwamoto Y. Giant cell tumor of bone: oncological and functional results of long-term follow-up. Jpn J Clin Oncol. 1998;28:323\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"1459_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1359\/jbmr.2000.15.4.640","volume":"15","author":"GJ Atkins","year":"2000","unstructured":"Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res. 2000;15:640\u20139.","journal-title":"J Bone Miner Res"},{"key":"1459_CR13","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","volume":"18","author":"DG Branstetter","year":"2012","unstructured":"Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res. 2012;18:4415\u201324.","journal-title":"Clin Cancer Res"},{"key":"1459_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","volume":"14","author":"S Chawla","year":"2013","unstructured":"Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, Kroep J, Grimer R, Reichardt P, Rutkowski P, et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol. 2013;14:901\u20138.","journal-title":"Lancet Oncol"},{"key":"1459_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","volume":"69","author":"M Campanacci","year":"1987","unstructured":"Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106\u201314.","journal-title":"J Bone Joint Surg Am"},{"key":"1459_CR16","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1302\/0301-620X.97B11.35326","volume":"97-B","author":"AA Salunke","year":"2015","unstructured":"Salunke AA, Chen Y, Chen X, Tan JH, Singh G, Tai BC, Khin LW, Puhaindran ME. Does pathological fracture affect the rate of local recurrence in patients with a giant cell tumour of bone?: a meta-analysis. Bone Joint J. 2015;97-B:1566\u201371.","journal-title":"Bone Joint J"},{"key":"1459_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00776-011-0030-x","volume":"16","author":"A Takeuchi","year":"2011","unstructured":"Takeuchi A, Tsuchiya H, Niu X, Ueda T, Jeon DG, Wang EH, Asavamongkolkul A, Kusuzaki K, Sakayama K, Kang YK. The prognostic factors of recurrent GCT: a cooperative study by the Eastern Asian Musculoskeletal Oncology Group. J Orthop Sci. 2011;16:196\u2013202.","journal-title":"J Orthop Sci"},{"key":"1459_CR18","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s11999-010-1560-9","volume":"469","author":"FM Klenke","year":"2011","unstructured":"Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Recurrent giant cell tumor of long bones: analysis of surgical management. Clin Orthop Relat Res. 2011;469:1181\u20137.","journal-title":"Clin Orthop Relat Res"},{"key":"1459_CR19","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1245\/s10434-015-4634-9","volume":"22","author":"P Rutkowski","year":"2015","unstructured":"Rutkowski P, Ferrari S, Grimer RJ, Stalley PD, Dijkstra SP, Pienkowski A, Vaz G, Wunder JS, Seeger LL, Feng A, et al. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone. Ann Surg Oncol. 2015;22:2860\u20138.","journal-title":"Ann Surg Oncol"},{"key":"1459_CR20","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.2106\/JBJS.M.01332","volume":"96","author":"IW Mak","year":"2014","unstructured":"Mak IW, Evaniew N, Popovic S, Tozer R, Ghert M. A translational study of the neoplastic cells of Giant cell tumor of bone following neoadjuvant denosumab. J Bone Joint Surg Am. 2014;96:e127.","journal-title":"J Bone Joint Surg Am"},{"key":"1459_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","volume":"11","author":"D Thomas","year":"2010","unstructured":"Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11:275\u201380.","journal-title":"Lancet Oncol"},{"key":"1459_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.reprotox.2013.07.018","volume":"42","author":"JL Bussiere","year":"2013","unstructured":"Bussiere JL, Pyrah I, Boyce R, Branstetter D, Loomis M, Andrews-Cleavenger D, Farman C, Elliott G, Chellman G. Reproductive toxicity of denosumab in cynomolgus monkeys. Reprod Toxicol. 2013;42:27\u201340.","journal-title":"Reprod Toxicol"},{"key":"1459_CR23","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2106\/JBJS.K.00774","volume":"94","author":"S Adami","year":"2012","unstructured":"Adami S, Libanati C, Boonen S, Cummings SR, Ho PR, Wang A, Siris E, Lane J, Group FF-HW, Adachi JD, et al. Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. J Bone Joint Surg Am. 2012;94:2113\u20139.","journal-title":"J Bone Joint Surg Am"},{"key":"1459_CR24","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s11999-015-4249-2","volume":"473","author":"LA Aponte-Tinao","year":"2015","unstructured":"Aponte-Tinao LA, Piuzzi NS, Roitman P, Farfalli GL. A high-grade sarcoma arising in a patient with recurrent benign giant cell tumor of the proximal tibia while receiving treatment with denosumab. Clin Orthop Relat Res. 2015;473:3050\u20135.","journal-title":"Clin Orthop Relat Res"},{"key":"1459_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2106\/JBJS.17.00057","volume":"100","author":"C Errani","year":"2018","unstructured":"Errani C, Tsukamoto S, Leone G, Righi A, Akahane M, Tanaka Y, Donati DM. Denosumab may increase the risk of local recurrence in patients with giant-cell tumor of bone treated with curettage. J Bone Joint Surg Am. 2018;100:496\u2013504.","journal-title":"J Bone Joint Surg Am"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1459-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-018-1459-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1459-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:09:10Z","timestamp":1565204950000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-018-1459-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1459"],"URL":"https:\/\/doi.org\/10.1186\/s12957-018-1459-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of Nagoya University Graduate School and School of Medicine (Nagoya, Japan) and a waiver of informed consent was provided.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any financial or personal relationships with any other persons or organizations that could potentially and\/or inappropriately influence their work and conclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"160"}}